[1]冯路迦,张学东.自噬与HMGB1在糖尿病视网膜微血管病变和神经退行性变中的研究进展[J].眼科新进展,2020,40(4):392-395.[doi:10.13389/j.cnki.rao.2020.0091]
　FENG Lujia,ZHANG Xuedong.Research advances on autophagy and HMGB1 in retinal microangiopathy and neurodegeneration of patient with diabetic retinopathy[J].Recent Advances in Ophthalmology,2020,40(4):392-395.[doi:10.13389/j.cnki.rao.2020.0091]
点击复制

自噬与HMGB1在糖尿病视网膜微血管病变和神经退行性变中的研究进展/HTML
分享到：

《眼科新进展》[ISSN:1003-5141/CN:41-1105/R]

卷:
40卷
期数:
2020年4期
页码:
392-395
栏目:
文献综述
出版日期:
2020-04-05

文章信息/Info

Title:
Research advances on autophagy and HMGB1 in retinal microangiopathy and neurodegeneration of patient with diabetic retinopathy
作者:
冯路迦; 张学东
400016　重庆市，重庆医科大学附属第一医院眼科 重庆市眼科研究所 眼科学重庆市市级重点实验室
Author(s):
FENG Lujia; ZHANG Xuedong
Department of Ophthalmology，the First Affiliated Hospital of Chongqing Medical University，Chongqing Key Laboratory of Ophthalmology，Chongqing Eye Institute，Chongqing 400016，China
关键词:
糖尿病视网膜病变; 微血管病变; 神经退行性变; 自噬; 高迁移率族蛋白B1
Keywords:
diabetic retinopathy;  microangiopathy;  neurodegeneration;  autophagy;  high mobility group box protein 1
分类号:
R774.1
DOI:
10.13389/j.cnki.rao.2020.0091
文献标志码:
A
摘要:
糖尿病视网膜病变（diabetic retinopathy，DR）是由糖尿病所导致的最典型的微血管并发症之一。以往DR发病机制和治疗的研究主要集中在微血管；近年来，许多学者认为DR不仅仅是一种微血管病变，而且还伴有视网膜神经退行性变。近期研究表明，自噬与高迁移率族蛋白B1（high mobility group box protein 1，HMGB1）通过多条通路参与到糖尿病视网膜微血管病变和神经退行性变中，通过调控自噬或 HMGB1可能为DR治疗提供一种新的思路。本文就自噬与 HMGB1 在糖尿病视网膜微血管病变和神经退行性变发病中的研究进展进行综述。
Abstract:
Diabetic retinopathy (DR) is one of the most typical microvascular complications caused by diabetes. Previous studies on the pathogenesis and treatment of DR mainly focus on the microangiopathy. In recent years, many researchers hold that DR is not only a microvascular disease, but accompanied by retinal neurodegeneration. Recent studies have shown that autophagy and high mobility group box protein 1 (HMGB1) are involved in the microangiopathy and neurodegeneration of DR through multiple pathways, which suggested that regulation of autophagy or HMGB1 may have therapeutic effects on DR. This article reviews the research progress of autophagy and HMGB1 in the microangiopathy and neurodegeneration of DR.

参考文献/References:

［1］　YAU J W，ROGERS S L，KAWASAKI R，LAMOUREUX E L，KOWALSKI J W，BEK T，et al.Global prevalence and major risk factors of diabetic retinopathy［J］.Diabetes Care，2012，35（3）：556-564.
［2］　LEASHER J L，BOURNE R R A，FLAXMAN S R，JONAS J B，KEEFFE J，NAIDOO K，et al.Global estimates on the number of people blind or visually impaired by diabetic retinopathy：A meta-analysis from 1990 to 2010［J］.Diabetes Care，2016，39（9）：1643-1649.
［3］　SOLOMON S D，CHEW E，DUH E J，SOBRIN L，SUN J K，VANDERBEEK B L，et al.Diabetic retinopathy：A position statement by the American Diabetes Association［J］.Diabetes Care，2017，40（9）：412-418.
［4］　GIACCO F，BROWNLEE M.Oxidative stress and diabetic complications［J］.Circ Res，2010，107（9）：1058-1070.
［5］　KAARNIRANTA K，XU H，KAUPPINEN A.Mechanistical retinal drug targets and challenges［J］.Adv Drug Deliv Rev，2018，15（2）：177-184.
［6］　AMATO R，CATALANI E，DAL MONTE M，CAMMALLERI M,DI RENZO I,PERROTTA C,et al.Autophagy-mediated neuroprotection induced by octreotide in an ex vivo，model of early diabetic retinopathy［J］.Pharmacol Res，2018，128：167-178.
［7］　DERETIC V，SAITOH T，AKIRA S.Autophagy in infection，inflammation and immunity［J］.Nat Rev Immunol，2013，13（10）：722-737.
［8］　FU D，YU J Y，YANG S，WU M，HAMMAD S M，CONNELL A R，et al.Survival or death：a dual role for autophagy in stress-induced pericyte loss in diabetic retinopathy［J］.Diabetologia，2016，59（10）：2251-2261.
［9］　LEVINE B，KROEMER G.Autophagy in the pathogenesis of disease［J］.Cell，2008，132（1）：27-42.
［10］　HAMMES H P.Diabetic retinopathy：hyperglycaemia，oxidative stress and beyond［J］.Diabetologia，2018，61（1）：29-38.
［11］　LOPES DE FARIA J M，DUARTE D A，MONTEMURRO C，PAPADIMITRIOU A，CONSONNI S R，LOPES DE FARIA J B.Defective autophagy in diabetic retinopathy［J］.Invest Ophthalmol Vis Sci，2016，57（10）：4356-4366.
［12］　MAO X B，YOU Z P，WU C，HUANG J.Potential suppression of the high glucose and insulin-induced retinal neovascularization by Sirtuin 3 in the human retinal endothelial cells.［J］.Biochem Biophys Res Commun，2017，482（2）：341-345.
［13］　DU J H，LI X，LI R，CHENG B X，KUERBANJIANG M，MA L.Role of autophagy in angiogenesis induced by a high-glucose condition in RF/6A cells［J］.Ophthalmologica，2017，237（2）：85-95.
［14］　FU D，YU J Y，CONNELL A R，YANG S，HOOKHAM M B，MCLEESE R，et al.Beneficial effects of berberine on oxidized LDL-induced cytotoxicity to human retinal müller cells［J］.Invest Ophthalmol Vis Sci，2016，57（7）：3369-3379.
［15］　SIM R，HERNNDEZ C.Neurodegeneration in the diabetic eye：new insights and therapeutic perspectives［J］.Trends Endocrinol Metab，2014，25（1）：23-33.
［16］　REN X，WANG N N，QI H，QIU Y Y，ZHANG C H，BROWN E，et al.Up-regulation thioredoxin inhibits advanced glycation end products-induced neurodegeneration［J］.Cell Physiol Biochem，2018，50（5）：1673-1686.
［17］　AMATO R，CATALANI E，DAL MONTE M，CAMMALLERI M，DI RENZO I，PERROTTA C，et al.Autophagy-mediated neuroprotection induced by octreotide in an ex-vivo，model of early diabetic retinopathy［J］.Pharmacol Res，2018，128（2）：167-178.
［18］　ANKITA，SAXENA S，NIM D K，STEFANICKOVA J，ZIAK P，STEFANICKA P，et al.Retinal photoreceptor apoptosis is associated with impaired serum ionized calcium homeostasis in diabetic retinopathy：An in-vivo analysis［J］.J Diabetes Compl，2019，33（3）：208-211.
［19］　FU D，YU J Y，YANG S，WU M，HAMMAD S M，CONNELL A R，et al.Survival or death：a dual role for autophagy in stress-induced pericyte loss in diabetic retinopathy［J］.Diabetologia，2016，59（10）：2251-2261.
［20］　KANG R，CHEN R，ZHANG Q，HOU W，WU S，CAO L，et al.HMGB1 in health and disease［J］.Mol Aspects Med，2014，40（12）：1-116.
［21］　XU T，JIANG L，WANG Z.The progression of HMGB1-induced autophagy in cancer biology［J］.Onco Targets Ther，2018，31（12）：365-377.
［22］　ANDERSSON U，YANG H，HARRIS H.High-mobility group box 1 protein （HMGB1） operates as an alarmin outside as well as inside cells［J］.Semin Immunol，2018，38（8）：40-48.
［23］　LOLMEDE K，CAMPANA L，VEZZOLI M，BOSURGI L，TONLORENZI R，CLEMENTI E，et al.Inflammatory and alternatively activated human macrophages attract vessel-associated stem cells，relying on separate HMGB1-and MMP-9-dependent pathways［J］.J Leukoc Biol，2009，85（5）：779-787.
［24］　ABU EL-ASRAR A M，NAWAZ M I，KANGAVE D，ABOUAMMOH M，MOHAMMAD G.High-mobility group Box-1 and endothelial cell angiogenic markers in the vitreous from patients with proliferative diabetic retinopathy［J］.Mediators Inflamm，2012，2012：1-7.
［25］　CHANG Y C，LIN C W，HSIEH M C，WU H J，WU W S，WU W C，et al.High mobility group B1 up-regulates angiogenic and fibrogenic factors in human retinal pigment epithelial ARPE-19 cells［J］.Cell Signal，2017，40（12）：248-257.
［26］　CHEN X L，ZHANG X D，LI Y Y，CHEN M，TANG R，RAN J.Involvement of HMGB1 mediated signalling pathway in diabetic retinopathy：evidence from type 2 diabetic rats and ARPE-19 cells under diabetic condition［J］.Br J Ophthalmol，2013，97（12）：1598-1603.
［27］　GONG Y，JIN X，WANG Q S，WEI S H，HOU B K，LI H Y，et al.The involvement of high mobility group 1 cytokine and phospholipases A2 in diabetic retinopathy［J］.Lipids Health Dis，2014，13（1）：156.
［28］　MOHAMMAD G，JOMAR D，SIDDIQUEI M M，ALAM K，ABU EL-ASRAR A M.High-mobility group Box-1 protein mediates the regulation of signal transducer and activator of transcription-3 in the diabetic retina and in human retinal müller cells［J］.Ophthalmic Res，2017，57（3）：150-160.
［29］　ABU EL-ASRAR A M，NAWAZ M I，SIDDIQUEI M M，AL-KHARASHI A S，KANGAVE D，MOHAMMAD G.High-mobility group Box-1 induces decreased brain-derived neurotrophic factor-mediated neuroprotection in the diabetic retina［J］.Mediators Inflamm，2013,2013:1-11.
［30］　ABU EL-ASRAR A M，MOHAMMAD G，NAWAZ M I，SIDDIQUEI M M.High-mobility group Box-1 modulates the expression of inflammatory and angiogenic signaling pathways in diabetic retina［J］.Curr Eye Res，2015，40（11）：1141-1152.
［31］　ELASRAR A M A，SIDDIQUEI M M，NAWAZ M I，MOHAMMAD G.The proinflammatory cytokine high-mobility group Box-1 mediates retinal neuropathy induced by diabetes［J］.Mediators Inflamm，2014,2014(11):746415.
［32］　ZHAO H，ZHANG J，YU J.HMGB-1 as a potential target for the treatment of diabetic retinopathy［J］.Med Sci Monit，2015，21（10）：3062-3067.
［33］　JIANG S，CHEN X.HMGB1 siRNA can reduce damage to retinal cells induced by high glucose in vitro and in vivo［J］.Drug Des Devel Ther，2017，11（3）：783-795.
［34］　WANG J，HAN D，SUN M，FENG J.Cerebral ischemic post conditioning induces autophagy inhibition and a HMGB1 secretion attenuation feedback loop to protect against ischemia reperfusion injury in an oxygen glucose deprivation cellular model［J］.Mol Med Rep，2016，14（5）：4162-4172.
［35］　XU J，JIANG Y，WANG J，SHI X，LIU Q，LIU Z，et al.Macrophage endocytosis of high-mobility group box 1 triggers pyroptosis［J］.Cell Death Differ，2014，21（8）：1229-1239.
［36］　MORINAGA Y，YANAGIHARA K，NAKAMURA S，HASEGAWA H，SEKI M，IZUMIKAWA K，et al.Legionella pneumophila induces cathepsin B-dependent necrotic cell death with releasing high mobility group box1 in macrophages［J］.Respir Res，2010，11（1）：158.
［37］　ZHU J R，LU H D，GUO C，FANG W R，ZHAO H D，ZHOU J S，et al.Berberine attenuates ischemia-reperfusion injury through inhibiting HMGB1 release and NF-κB nuclear translocation［J］.Acta Pharm Sin B，2018，39（11）：1706-1715.
［38］　NIKOLETOPOULOU V，MARKAKI M，PALIKARAS K，TAVERNARAKIS N.Crosstalk between apoptosis，necrosis and autophagy［J］.Biochim Biophys Acta，2013，1833 （12）：3448-3459.
［39］　VERMA N，MANNA S K.Advanced glycation end products （AGE） potently induce autophagy through activation of RAF protein kinase and nuclear factor κB （NF-κB）［J］.J Biol Chem，2016，291（3）：1481-1491.

相似文献/References:

[1]杜玮 刘子扬 周艳艳 雒雷鸣.糖尿病视网膜病变与血清胆红素水平的关系[J].眼科新进展,2012,32(5):000.
[2]范松涛 卢建民.阿司匹林与糖尿病患者玻璃体出血以及玻璃体切割术疗效的相关性研究[J].眼科新进展,2012,32(11):000.
[3]李艳 李筱荣 袁佳琴 潘斌.糖尿病大鼠视网膜中VEGF、PEDF的表达与血-视网膜屏障损伤[J].眼科新进展,2013,33(1):000.
[4]李朝晖 崔治华 胡晓英 孟丽珠 张敬维.糖尿病视网膜病变激光面积与疗效的分析[J].眼科新进展,2013,33(2):000.
[5]冯冬梅 朱鸿 施彩虹.CXC趋化因子及其受体在糖尿病视网膜病变中的作用[J].眼科新进展,2013,33(6):000.
[6]牛淑玲.糖尿病视网膜病变患者HbAlc、FPG与血小板参数的变化及危险因素分析[J].眼科新进展,2013,33(7):000.
[7]毕春潮 王睿 王建洲 雷春灵 董晓娟 王小莉 薛晓辉.Ad-PEDF对糖尿病视网膜病变大鼠视网膜新生血管的抑制作用[J].眼科新进展,2013,33(8):000.
[8]杨萍 孙书明 李晓鹏.辛伐他汀对糖尿病视网膜病变和炎症因子的影响[J].眼科新进展,2013,33(8):000.
[9]罗文婷 孙大卫.血管黏附蛋白-1在眼科疾病中的研究进展[J].眼科新进展,2013,33(8):000.
[10]李小璐 马雅玲.糖尿病视网膜病变大鼠视网膜VEGF和PEDF的动态表达[J].眼科新进展,2013,33(9):000.
[11]李艳,利虹瑛,张梦圆,等.G 蛋白偶联受体在糖尿病视网膜病变发病过程中的作用[J].眼科新进展,2021,41(7):680.[doi:10.13389/j.cnki.rao.2021.0141]
　LI Yan,LI Hongying,ZHANG Mengyuan,et al.Role of G protein coupled receptors in the pathogenesis of diabetic retinopathy[J].Recent Advances in Ophthalmology,2021,41(4):680.[doi:10.13389/j.cnki.rao.2021.0141]

备注/Memo

备注/Memo:
国家自然科学基金资助项目（编号：81870673）
更新日期/Last Update: 2020-04-05